<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03052569</url>
  </required_header>
  <id_info>
    <org_study_id>RXDX-105 - EAP</org_study_id>
    <nct_id>NCT03052569</nct_id>
  </id_info>
  <brief_title>Expanded Access to RXDX-105 for Cancers With RET Alterations</brief_title>
  <official_title>Expanded Access to RXDX-105 for the Treatment of Cancers With RET Alterations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ignyta, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ignyta, Inc.</source>
  <brief_summary>
    <textblock>
      Expanded access to RXDX-105 will be given to patients with cancers harboring RET alterations
      who have not received TKIs that target RET alterations, who do not qualify for participation
      in, or who are otherwise unable to access, an ongoing clinical trial for RXDX-105.
    </textblock>
  </brief_summary>
  <overall_status>Temporarily not available</overall_status>
  <study_type>Expanded Access</study_type>
  <condition>Cancers With RET Alterations</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RXDX-105</intervention_name>
    <description>Oral Capsules</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of advanced cancer with RET alterations

          -  Unable to participate in an ongoing RXDX-105 clinical trial

          -  Willing and able to provide written, signed informed consent

          -  Medically suitable for treatment with RXDX-105

        Exclusion Criteria:

          -  Prior treatment with a TKI that has activity against RET alterations

          -  Currently enrolled in an ongoing clinical study with any other investigational agent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Www.Ignyta.Com</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2017</study_first_submitted>
  <study_first_submitted_qc>February 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2017</study_first_posted>
  <last_update_submitted>August 14, 2017</last_update_submitted>
  <last_update_submitted_qc>August 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

